(Q83399088)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Philippe Denoël

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Fabrice Godfroid

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Philippe Hermand

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Vincent Verlant

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jan Poolman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

11 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

6451-6453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

Clinical features, aetiology and outcome of empyema in children in the north east of England

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Serotypes and pathogens in paediatric pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Kinetics of the immune response following pneumococcal PD conjugate vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.085

10.1016/J.VACCINE.2011.01.085

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315695%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference